Posted in | News | Nanomedicine | Nanoanalysis

Silver Nanoparticle Biotags for Identifying Cancerous Prostate Cells

UC Santa Barbara researchers have developed a novel technology for distinguishing prostate cancer cells in bodily fluids. The technology holds potential for developing a microdevice that would help understand when metastasis of prostate cancer would occur.

When there is more number of cancer cells in a patient’s blood the prognosis is worse. In prostate cancer patients, death is caused by metastasis and not by the primary tumor. Finding and recognizing cancer cells within bodily fluids could help in diagnosis and treatment for the cancer.

Cancerous and non-cancerous cells are incubated with silver nanoparticle biotags, and then analyzed by shining the red laser on them. The biotags are shown on the cells' surface. Those glowing red in the middle are the cancer biomarkers, and those glowing green are standard biomarkers that bind to many cell types. A high ratio of red to green is found on the cancer cells. Credit: Gary Braun and Peter Allen/UCSB

UCSB researchers employed surface enhanced Raman spectroscopy (SERS), a kind of laser spectroscopy, and silver nanoparticles as biotags for this technique in order to differentiate between non-cancerous cells and cancerous cells. When silver nanoparticles absorb laser light they have the ability to emit a set of colors. This emission is not fluorescent.

The researchers are trying to add more markers for identifying unique tumor cells which are not like the main tumor cells. They intend to mix nanoparticles with cancerous cells and then pass them through a laser. The cells would then be differentiated by their signal ratios.

The team used two kinds of biotags. One type binds to both non-cancerous and cancerous cells, while the other has an affinity to neuropilin-1, a cell receptor that is found on certain types of cancerous cells. The researchers mixed the two types of biotags and then added them to cultures of cancerous and healthy cells. In the analysis, an average SERS signal provided a signal ratio that was consistent with the known identity of a cell.

The findings of the study have been published in Proceedings of the National Academy of Sciences.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 12). Silver Nanoparticle Biotags for Identifying Cancerous Prostate Cells. AZoNano. Retrieved on November 23, 2024 from https://www.azonano.com/news.aspx?newsID=23425.

  • MLA

    Chai, Cameron. "Silver Nanoparticle Biotags for Identifying Cancerous Prostate Cells". AZoNano. 23 November 2024. <https://www.azonano.com/news.aspx?newsID=23425>.

  • Chicago

    Chai, Cameron. "Silver Nanoparticle Biotags for Identifying Cancerous Prostate Cells". AZoNano. https://www.azonano.com/news.aspx?newsID=23425. (accessed November 23, 2024).

  • Harvard

    Chai, Cameron. 2019. Silver Nanoparticle Biotags for Identifying Cancerous Prostate Cells. AZoNano, viewed 23 November 2024, https://www.azonano.com/news.aspx?newsID=23425.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.